ACTIVE_NOT_RECRUITING

Remote Alcohol Monitoring to Facilitate Abstinence From Alcohol: Exp 1

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Directly reinforcing abstinence from alcohol with monetary incentives is an effective treatment for alcohol dependence, but barriers in obtaining frequent, verified biochemical measures of abstinence limit the dissemination of this treatment approach. The goal of this study is to use technological advancements to remotely, accurately, and securely monitor alcohol use with a newly developed smartphone app and breathalyzer. This treatment approach has the potential to facilitate the dissemination of an effective, evidence-based treatment for alcohol dependence to a broader population whose treatment needs are not currently being adequately met.

Official Title

Remote Alcohol Monitoring to Facilitate Abstinence Reinforcement With an Underserved Population

Quick Facts

Study Start:2020-06-16
Study Completion:2026-12-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT03883126

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Meet Diagnostic and Statistical Manual (DSM)-5 criteria for alcohol use disorder
  2. * Average 3 or more heavy drinking days (≥5 drinks in one occasion for men, ≥4 for women) per week for the past month on the Timeline Follow-back.
  3. * Must endorse alcohol as their primary drug of use.
  4. * Express a desire to abstain from drinking.
  1. * Are currently enrolled in an alcohol treatment program (not including attendance at Alcoholics Anonymous or similar community support meetings).
  2. * Score 23 or greater on the Alcohol Withdrawal Symptom Checklist, a score indicating that medication would be likely required to manage alcohol detoxification.
  3. * Pregnant women, lactating women, or women who are planning to become pregnant in the next 15 months.

Contacts and Locations

Study Locations (Sites)

Nationwide Online Enrollment from the Unversity of Kentucky
Lexington, Kentucky, 40504
United States
University of Kentucky Turfland: In-person enrollment
Lexington, Kentucky, 40504
United States
Carilion Clinic: In person-enrollment
Roanoke, Virginia, 24014
United States

Collaborators and Investigators

Sponsor: Mikhail N Koffarnus

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-06-16
Study Completion Date2026-12-01

Study Record Updates

Study Start Date2020-06-16
Study Completion Date2026-12-01

Terms related to this study

Additional Relevant MeSH Terms

  • Alcohol Use Disorder